{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:15:17Z","timestamp":1776352517523,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10096-025-05385-1","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:13:54Z","timestamp":1766160834000},"page":"1177-1184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literature"],"prefix":"10.1007","volume":"45","author":[{"given":"Gabriele","family":"Giuliano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Sambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laerta","family":"Dulislami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Zanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Michielon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Marianello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Puddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Catelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Luzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Cusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Fabbiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Tumbarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Montagnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"5385_CR1","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.21037\/jtd-2021-12","volume":"13","author":"M McCort","year":"2021","unstructured":"McCort M, MacKenzie E, Pursell K, Pitrak D (2021) Bacterial infections in lung transplantation. J Thorac Dis 13:6654\u20136672. https:\/\/doi.org\/10.21037\/jtd-2021-12","journal-title":"J Thorac Dis"},{"issue":"7","key":"5385_CR2","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.transproceed.2017.11.080","volume":"50","author":"J Wojarski","year":"2018","unstructured":"Wojarski J, Ochman M, Medrala W, Kulaczkowska Z, Karolak W, Maruszewski M et al (2018) Bacterial infections during hospital stay and their impact on mortality after lung transplantation: a single-center study. Transplant Proc 50(7):2064\u20132069. https:\/\/doi.org\/10.1016\/j.transproceed.2017.11.080","journal-title":"Transplant Proc"},{"issue":"6","key":"5385_CR3","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3390\/microorganisms11061468","volume":"11","author":"E Farfour","year":"2023","unstructured":"Farfour E, Roux A, Sage E, Revillet H, Vasse M, Vall\u00e9e A (2023) Rarely encountered Gram-Negative rods and lung transplant recipients: a narrative review. Microorganisms 11(6):1468. https:\/\/doi.org\/10.3390\/microorganisms11061468","journal-title":"Microorganisms"},{"issue":"3","key":"5385_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.idc.2018.04.004","volume":"32","author":"M Bartoletti","year":"2018","unstructured":"Bartoletti M, Giannella M, Tedeschi S, Viale P (2018) Multidrug-resistant bacterial infections in solid organ transplant candidates and recipients. Infect Dis Clin North Am 32(3):551\u2013580. https:\/\/doi.org\/10.1016\/j.idc.2018.04.004","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"5385_CR5","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s10096-021-04153-1","volume":"40","author":"L Paglicci","year":"2021","unstructured":"Paglicci L, Borgo V, Lanzarone N, Fabbiani M, Cassol C, Cusi MG (2021) Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients. Eur J Clin Microbiol Infect Dis 40(6):1271\u20131282. https:\/\/doi.org\/10.1007\/s10096-021-04153-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5385_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","volume":"21","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R (2021) Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis 21:226\u201340. https:\/\/doi.org\/10.1016\/S1473-3099(20)30796-9","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"5385_CR7","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB (2016) Management of adults with Hospital-acquired and Ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis 63(5):e61\u2013e111. https:\/\/doi.org\/10.1093\/cid\/ciw353","journal-title":"Clin Infect Dis"},{"issue":"7","key":"5385_CR8","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1093\/cid\/ciaa1478","volume":"72","author":"PD Tamma","year":"2021","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ (2021) Infectious Diseases Society of America guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis 72(7):e169\u2013e183. https:\/\/doi.org\/10.1093\/cid\/ciaa1478","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5385_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106818","volume":"62","author":"C de la Fuente","year":"2023","unstructured":"de la Fuente C, Rodr\u00edguez M, Merino N, Carmona P, Machuca I, C\u00f3rdoba-Fern\u00e1ndez M (2023) Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria. Int J Antimicrob Agents 62(1):106818","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"5385_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14319","volume":"26","author":"PN Persaud","year":"2024","unstructured":"Persaud PN, Xhemali X, Neuhaus K, Budev M, Lum J (2024) Cefiderocol utilization in lung transplant recipients at a single center. Transpl Infect Dis 26(4):e14319. https:\/\/doi.org\/10.1111\/tid.14319","journal-title":"Transpl Infect Dis"},{"key":"5385_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.10.014","author":"M Gatti","year":"2021","unstructured":"Gatti M, Bartoletti M, Cojutti PG, Gaibani P, Conti M, Giannella M (2021) A descriptive case series of pharmacokinetic\/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and\/or ventilator-associated pneumonia treated with cefiderocol. J Glob Antimicrob Resist. https:\/\/doi.org\/10.1016\/j.jgar.2021.10.014","journal-title":"J Glob Antimicrob Resist"},{"key":"5385_CR12","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1093\/jac\/dkz123","volume":"74","author":"T Katsube","year":"2019","unstructured":"Katsube T, Saisho Y, Shimada J, Furuie H (2019) Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects. J Antimicrob Chemother 74:1971\u20131974. https:\/\/doi.org\/10.1093\/jac\/dkz123","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"5385_CR13","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1093\/jac\/dkab280","volume":"76","author":"T Katsube","year":"2021","unstructured":"Katsube T, Nicolau DP, Rodvold KA, Wunderink RG, Echols R, Matsunaga Y (2021) Intrapulmonary pharmacokinetic profile of Cefiderocol in mechanically ventilated patients with pneumonia. J Antimicrob Chemother 76(11):2902\u20132905. https:\/\/doi.org\/10.1093\/jac\/dkab280","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5385_CR14","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1093\/cid\/ciaa1847","volume":"73","author":"NC Warner","year":"2021","unstructured":"Warner NC, Bartelt LA, Lachiewicz AM, Tompkins KM, Miller MB, Alby K (2021) Cefiderocol for the treatment of adult and pediatric patients with cystic fibrosis and Achromobacter xylosoxidans infections. Clin Infect Dis 73(7):e1754\u2013e1757","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5385_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106825","volume":"62","author":"A Russo","year":"2023","unstructured":"Russo A, Bruni A, Gull\u00ec S, Borrazzo C, Quirino A, Lionello R (2023) Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19. Int J Antimicrob Agents 62(1):106825. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106825","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"5385_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlad085","volume":"5","author":"E Rando","year":"2023","unstructured":"Rando E, Cutuli SL, Sangiorgi F, Tanzarella ES, Giovannenze F, De Angelis G (2023) Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study. JAC-Antimicrobial Resistance 5(4):dlad085","journal-title":"JAC-Antimicrobial Resistance"},{"key":"5385_CR17","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.2147\/IDR.S475462","volume":"17","author":"CJ Clancy","year":"2024","unstructured":"Clancy CJ, Cornely OA, Marcella SW, Nguyen ST, Gozalo L, Cai B (2024) Effectiveness and safety of cefiderocol in clinical practice for treatment of patients with gram-negative bacterial infections: US interim results of the PROVE study. Infect Drug Resist 17:4427\u20134443. https:\/\/doi.org\/10.2147\/IDR.S475462","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5385_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106376","volume":"90","author":"S Soueges","year":"2025","unstructured":"Soueges S, Faure E, Parize P, Lanternier-Dessap F, Lecuyer H, Huynh A, G2I (Groupe Immunodepression et Infections) network (2025) Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant gram-negative bacteria: CEFI-ID. J Infect 90(1):106376. https:\/\/doi.org\/10.1016\/j.jinf.2024.106376","journal-title":"J Infect"},{"issue":"12","key":"5385_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11121830","volume":"11","author":"S Mornese Pinna","year":"2022","unstructured":"Mornese Pinna S, Corcione S, De Nicol\u00f2 A, Montrucchio G, Scabini S, Vita D (2022) Pharmacokinetic of cefiderocol in critically ill patients receiving renal replacement therapy: a case series. Antibiotics 11(12):1830. https:\/\/doi.org\/10.3390\/antibiotics11121830","journal-title":"Antibiotics"},{"issue":"3","key":"5385_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmi.2022.11.005","volume":"29","author":"B Hoellinger","year":"2023","unstructured":"Hoellinger B, Simand C, Jeannot K, Garijo C, Cristinar M, Reisz F (2023) Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series. Clin Microbiol Infect 29(3):393\u2013395. https:\/\/doi.org\/10.1016\/j.cmi.2022.11.005","journal-title":"Clin Microbiol Infect"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05385-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:33:55Z","timestamp":1776350035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5385"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05385-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients signed informed consent according to MDR_LTx study, approved by the Regional Ethics Committee for Clinical Trials of the Tuscany Region (Section: Area Vasta Sud-Est) with protocol number 23569.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics statement"}},{"value":"\u00a0The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Transparency declaration"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}